Zobrazeno 1 - 10
of 133
pro vyhledávání: '"Mark R, Nehler"'
Autor:
Anya L. Greenberg, MBA, Jenny R. Cevallos, BS, Feyisayo M. Ojute, BS, Denise L. Davis, MD, Wendy R. Greene, MD, Carter C. Lebares, MD, for the General Surgery Research Collaborative on Resident Wellbeing, Celia Divino, MD, Jennifer N. Choi, MD, Jennifer E. Hrabe, MD, Julia S. Shelton, MD, MPH, Christopher M. Foglia, MD, Varuna Sundaram, MD, Brooke Gurland, MD, FACS, David A. Spain, MD, Matthew Hanlon, MD, Andreas H. Meier, MD, MEd, Dr med, Kelly R. Haisley, MD, Alan Harzman, MD, Emily Huang, MD, Jennifer Preston, MD, Valentine Nfonsam, MD, MS, Taylor S. Riall, MD, PhD, FACS, Barnard J. A. Palmer, MD, MEd, Gregory P. Victorino, MD, Tim R. Donahue, MD, Veronica F. Sullins, MD, Anya Greenberg, MBA, Kenzo Hirose, MD, Carter Lebares, MD, Linda M. Reilly, MD, Kshama R. Jaiswal, MD, Mark R. Nehler, MD, Melissa Brunsvold, MD, Daniel E. Kendrick, MD, M. Timothy Nelson, MD, Robert B. Lim, MD, Karen D. Horvath, MD, Lorrie A. Langdale, MD, FACS, Rebecca Maine, MD, MPH
Publikováno v:
Annals of Surgery Open, Vol 3, Iss 3, p e187 (2022)
Objectives:. We explored differences by race/ethnicity in regard to several factors that reflect or impact wellbeing. Background:. Physician wellbeing has critical ramifications for the US healthcare system, affecting clinical outcomes, patient exper
Externí odkaz:
https://doaj.org/article/28b8a3fda0c04f798076a158fd8d26da
Autor:
Connie N. Hess, Iris Baumgartner, Sonia S. Anand, Mark R. Nehler, Manesh R. Patel, E. Sebastian Debus, Michael Szarek, Warren Capell, Eva Muehlhofer, Scott D. Berkowitz, Lloyd P. Haskell, Rupert M. Bauersachs, Marc P. Bonaca, Judith Hsia
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 12 (2022)
Background Despite high female prevalence of peripheral artery disease (PAD), little is known about sex‐based outcomes after lower extremity revascularization (LER) for symptomatic PAD. The effects of rivaroxaban according to sex following LER have
Externí odkaz:
https://doaj.org/article/e206edcaf2794bc898a22f84d5fb18a2
Autor:
Limael E. Rodriguez, John C. Eun, Ryan T. Calkins, Adam M. Carroll, Emily A. Malgor, Max V. Wohlauer, Mark R. Nehler, Donald L. Jacobs, Rafael D. Malgor
Publikováno v:
Annals of Vascular Surgery. 89:28-35
The aim of this study is to compare how instructions for use (IFU) affected perioperative and intermediate term outcomes for common iliac artery aneurysms (CIAA) treated with the Gore Excluder iliac branch endoprosthesis (IBE).A retrospective analysi
Autor:
Marc P. Bonaca, Michael Szarek, E. Sebastian Debus, Mark R. Nehler, Manesh R. Patel, Sonia S. Anand, Eva Muehlhofer, Scott D. Berkowitz, Lloyd P. Haskell, Rupert M. Bauersachs
Publikováno v:
Clinical Cardiology. 45:1143-1146
The Clopidogrel and Acetylsalicylic Acid in Bypass Surgery for Peripheral Arterial Disease (CASPAR) trial is the only large, double-blind, placebo-controlled trial of dual antiplatelet therapy (DAPT) versus aspirin in patients with peripheral artery
Autor:
Behnood Bikdeli, Candrika D. Khairani, Darsiya Krishnathasan, Antoine Bejjani, Andre Armero, Anthony Tristani, Julia Davies, Nicole Porio, Ali A. Assi, Victor Nauffal, Umberto Campia, Zaid Almarzooq, Eric Wei, Aditya Achanta, Sirus J. Jesudasen, Bruce C. Tiu, Geno J. Merli, Orly Leiva, John Fanikos, Aditya Sharma, Alec Vishnewsky, Judith Hsia, Mark R. Nehler, James Welker, Marc P. Bonaca, Brett J. Carroll, Zhou Lan, Samuel Z. Goldhaber, Gregory Piazza
Publikováno v:
Thrombosis Research.
Autor:
Scott D. Berkowitz, Rupert M. Bauersachs, Michael Szarek, Mark R. Nehler, E. Sebastian Debus, Manesh R. Patel, Sonia S. Anand, Warren H. Capell, Connie N. Hess, Judy Hsia, Nicholas J. Leeper, David Brasil, Lajos Mátyás, Rafael Diaz, Marianne Brodmann, Eva Muehlhofer, Lloyd P. Haskell, Marc P. Bonaca
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:1193-1205
Vascular disease burden after lower extremity revascularization (LER) comprises more than the first event, more vascular beds than the local arteries, and more than one clinical event type.Assess total arterial and venous thrombotic burden after LER
Autor:
Mark R. Nehler, Alden Harken
Publikováno v:
Peripheral Arterial Disease Handbook ISBN: 9780429191497
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a21da62ddd580196e65e1d65ec6ac85c
https://doi.org/10.1201/9780429191497-17
https://doi.org/10.1201/9780429191497-17
Autor:
Sonia S. Anand, Judith Hsia, Marianne Brodmann, Marc P. Bonaca, Henrik Sillesen, Nicholas J. Leeper, E. Sebastian Debus, Eva Muehlhofer, Connie N. Hess, Joshua A. Beckman, Peter Habertheuer, Rafael Diaz, Rupert Bauersachs, Michael Szarek, Scott D. Berkowitz, Manesh R. Patel, Richard J. Powell, Lloyd Haskell, Mark R. Nehler, Warren H. Capell
Publikováno v:
Hess, C N, Debus, E S, Nehler, M R, Anand, S S, Patel, M R, Szarek, M, Capell, W H, Hsia, J, Beckman, J A, Brodmann, M, Diaz, R, Habertheuer, P, Leeper, N J, Powell, R J, Sillesen, H, Muehlhofer, E, Berkowitz, S D, Haskell, L P, Bauersachs, R M & Bonaca, M P 2021, ' Reduction in Acute Limb Ischemia With Rivaroxaban Versus Placebo in Peripheral Artery Disease After Lower Extremity Revascularization : Insights From VOYAGER PAD ', Circulation, vol. 144, no. 23, pp. 1831-1841 . https://doi.org/10.1161/CIRCULATIONAHA.121.055146
Background: Patients with peripheral artery disease (PAD) are at heightened risk of acute limb ischemia (ALI), a thrombotic event associated with amputation, disability, and mortality. Previous lower extremity revascularization (LER) is associated wi
Autor:
Marc P. Bonaca, Eric A. Secemsky, Mark R. Nehler, Rupert Bauersachs, Robert W. Yeh, Warren H. Capell, Manesh R. Patel, Sonia S. Anand, Eva Muehlhofer, Lloyd Haskell, Nicholas Govsyeyev, Connie N. Hess, Taylor Brackin, William R. Hiatt, E. Sebastian Debus, Joshua A. Beckman, Fabrizio Fanelli, Laura Mauri, Scott D. Berkowitz
Publikováno v:
Journal of the American College of Cardiology. 78:1768-1778
Background Paclitaxel drug-coated devices (DCDs) were developed to improve lower extremity revascularization (LER) patency in peripheral artery disease (PAD) but have been associated with long-term mortality. Objectives This study assessed DCD safety
Autor:
Sebastian Debus, Lloyd Haskell, Marc P. Bonaca, Manesh R. Patel, Eva Muehlhofer, Michael Szarek, Mori J. Krantz, Patrice Nault, Sonia S. Anand, Lajos Mátyás, William R. Hiatt, Rupert Bauersachs, Judith Hsia, Mark R. Nehler, Warren H. Capell, Dainis Krievins, Scott D. Berkowitz, Stefan Stefanov, Connie N. Hess, Taylor Bracken
Publikováno v:
European Heart Journal. 42:4040-4048
Aims In this secondary analysis of the VOYAGER trial, rivaroxaban 2.5 mg twice/day plus aspirin 100 mg/day was assessed in older adults. Advanced age is associated with elevated bleeding risk and unfavourable net benefit for dual antiplatelet therapy